Allergan plc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Allergan plc with three other
companies in this sector in the United States:
Takeda Pharmaceutical Company Limited
sales of $16.01 billion
of which 96%
was Pharmaceutical Business),
of which 100%
was Biopharmaceuticals), and
Novo Nordisk As
of which 84%
was Diabetes and obesity).
Allergan plc reported sales of $15.79 billion
December of 2018.
decrease of 1.0%
versus 2017, when the company's sales were $15.94 billion.
Contributing to the drop in overall sales was the 8.2% decline
in Us General Medicine, from $5.80 billion to $5.32 billion.
However, these declines were partially offset by the increase in sales of
Us Specialized Therapeutics (up 1.7% to $6.92 billion)
International (up 5.6% to $3.50 billion)
Other (up 84.6% to $39.50 million)